Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol vs Metoprolol Long-term Effects in Hypertension
NCT00142584Phase 3Completed
- Sponsor
- Viatris
- Start
- Aug 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of nebivolol in hypertension (HTN) (2 arms), sponsored by Viatris. Primary endpoint: Change in Average Sitting Diastolic Blood Pressure (DBP) Taken at Trough at the End of Treatment Compared to Baseline at 18 months. Started Aug 2005; status: completed.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00142584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00142584.